Ashiq Mubarack

Stock Analyst at Citigroup

(0.92)

# 3,540

Out of 4,789 analysts

3

Total ratings

66.67%

Success rate

-16.96%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$6 → $5	$0.33	+1,395.66%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$2.50	+220.00%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $6 → $5

Current: $0.33

Upside: +1,395.66%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $2.50

Upside: +220.00%